Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device pro… Read more
Market Cap & Net Worth: Shandong Weigao Group Medical Polymer Company Limited (UK2)
Shandong Weigao Group Medical Polymer Company Limited (F:UK2) has a market capitalization of $2.35 Billion (€2.29 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #6421 globally and #681 in its home market, demonstrating a -3.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Weigao Group Medical Polymer Company Limited's stock price €0.51 by its total outstanding shares 4481453524 (4.48 Billion).
Shandong Weigao Group Medical Polymer Company Limited Market Cap History: 2015 to 2026
Shandong Weigao Group Medical Polymer Company Limited's market capitalization history from 2015 to 2026. Data shows growth from $519.35 Million to $2.35 Billion (16.58% CAGR).
Shandong Weigao Group Medical Polymer Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Weigao Group Medical Polymer Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.20x
Shandong Weigao Group Medical Polymer Company Limited's market cap is 0.20 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.24x
Shandong Weigao Group Medical Polymer Company Limited's market cap is 1.24 times its annual earnings
841.57x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $519.35 Million | $5.92 Billion | $1.11 Billion | 0.09x | 0.47x |
| 2016 | $621.47 Million | $6.73 Billion | $1.11 Billion | 0.09x | 0.56x |
| 2017 | $710.71 Million | $6.29 Billion | $1.73 Billion | 0.11x | 0.41x |
| 2018 | $1.02 Billion | $8.81 Billion | $1.47 Billion | 0.12x | 0.69x |
| 2019 | $1.75 Billion | $10.36 Billion | $1.84 Billion | 0.17x | 0.95x |
| 2020 | $3.33 Billion | $11.35 Billion | $2.03 Billion | 0.29x | 1.64x |
| 2021 | $2.34 Billion | $13.15 Billion | $2.24 Billion | 0.18x | 1.04x |
| 2022 | $3.79 Billion | $13.62 Billion | $2.72 Billion | 0.28x | 1.39x |
| 2023 | $2.52 Billion | $13.23 Billion | $2.00 Billion | 0.19x | 1.26x |
| 2024 | $2.55 Billion | $13.09 Billion | $2.07 Billion | 0.20x | 1.24x |
Competitor Companies of UK2 by Market Capitalization
Companies near Shandong Weigao Group Medical Polymer Company Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Shandong Weigao Group Medical Polymer Company Limited by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #99 globally with a market cap of $170.64 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #355 globally with a market cap of $61.46 Billion USD ( €59.87 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.52 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #99 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.64 Billion | $483.46 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #355 | EssilorLuxottica S. A. | PA:EL | $61.46 Billion | €203.90 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.52 Billion | $160.27 |
Shandong Weigao Group Medical Polymer Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Shandong Weigao Group Medical Polymer Company Limited's market cap moved from $519.35 Million to $ 2.35 Billion, with a yearly change of 16.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.35 Billion | -2.86% |
| 2025 | €2.42 Billion | -5.41% |
| 2024 | €2.55 Billion | +1.35% |
| 2023 | €2.52 Billion | -33.56% |
| 2022 | €3.79 Billion | +62.21% |
| 2021 | €2.34 Billion | -29.83% |
| 2020 | €3.33 Billion | +90.20% |
| 2019 | €1.75 Billion | +71.33% |
| 2018 | €1.02 Billion | +43.82% |
| 2017 | €710.71 Million | +14.36% |
| 2016 | €621.47 Million | +19.66% |
| 2015 | €519.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shandong Weigao Group Medical Polymer Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.35 Billion USD |
| MoneyControl | $2.35 Billion USD |
| MarketWatch | $2.35 Billion USD |
| marketcap.company | $2.35 Billion USD |
| Reuters | $2.35 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.